CLN2 DISEASE EDUCATIONAL WEBINAR SERIES

The importance of early genetic testing in pediatric epilepsy

Insights from the CLN2 disease experience

English video thumbnail

Runtime: 01:08:51

PLAY IN ENGLISH

DOWNLOAD SLIDES IN ENGLISH STAY INFORMED

If you wish to stay informed about other CLN2 disease resources
please register via the button above.


The Agenda
Introduction Nicola Specchio
Epilepsy and Genetics Raman Sankar
CLN2 Disease and the Need for Early Diagnosis Nicola Specchio
Genetic Testing and Actionability of Results Raman Sankar
Case Study Nicola Specchio
Interactive Q&A


Our Faculty

Nicola Specchio Bambino Gesù Children’s
Hospital, IRCCS

Rome, Italy
Raman Sankar David Geffen School of Medicine at UCLA
Los Angeles, CA, USA

What you will learn

Genetic research is rapidly advancing our understanding of the underlying causes of epilepsy. Early genetic testing in pediatric epilepsy patients can help uncover devastating disorders, like CLN2 disease, earlier in the course of the disease. Learn more about diagnostic testing options which could uncover the underlying cause of a seizure. A definitive diagnosis can enable more precise clinical management and improve patient outcomes, in some cases.


This program is developed for healthcare professionals interested in learning about the importance of genetic testing in pediatric epilepsy patients.


No CME credit will be offered for this webinar
This webinar was developed and funded by BioMarin